Lymphoma Coalition is pleased to attend the American Society of Hematology (ASH) symposium in New Orleans this weekend, presenting Poster Abstract #3537: “Patient Reported Experience with Fatigue, a Cross-Sectional Study Examining Indolent and Aggressive Lymphomas.”
The presentation will take place Sunday, Dec 11th: from 6:00 PM-8:00. Session 902. Health Services and Quality—Lymphoid Malignancies- Location: Ernest N. Morial Convention Center, Hall D. Title: Patient Reported Experience with Fatigue, a Cross-Sectional Study Examining Indolent and Aggressive Lymphomas. Cherie Bates, Lymphoma Coalition’s Head of Research & Information will be leading the session.
Curious to learn more? You can find Lymphoma Coalition at booth #2728 all weekend long!
Lymphoma Coalition is looking forward to sharing our latest research on the patient experience with the hematology community and exhibiting at #ASH22.
You can view and download the materials that will be distributed at our booth below:
Chronic Lymphocytic Leukaemia (CLL) Report
The focus of this report is to:
• Provide a current understanding of CLL
• Explain the diagnosis and pre-treatment process
• Outline CLL treatment options and protocols, including:
– Therapy access in Lymphoma Coalition (LC) member countries
– Clinical trial access in LC member countries
• Highlight Covid-19-related considerations for patients with CLL
• Explore the experience of patients with CLL
Cancer-Related Fatigue Toolkit
Cancer-related fatigue (CRF) is one of the most common symptoms experienced by patients with, and survivors of, cancer. It is more severe, more distressing and less likely to be relieved by rest than the tiredness or fatigue of daily life. To help patients cope with the impacts of CRF, we have created the following resources. Documents Cancer-related Fatigue Overview: […]
Lymphoma Coalition Europe Report
The objectives of the 2022 Lymphoma Care in Europe report are to:
1. Examine the burden of lymphoma (disease burden and economic impact) in Europe.
2. Spotlight the experience of patients with lymphoma and why this experience matters for healthcare decision-making.
3. Identify and make recommendations for future lymphoma advocacy initiatives in Europe.
Fear of Cancer Recurrence Toolkit
Fear of Cancer Recurrence Fear of cancer recurrence (FCR) is defined as fear, worry or concern relating to the possibility that cancer will come back or progress. FCR is among the most commonly reported psychosocial issues for cancer survivors. It affects people with all types of cancer, and it may continue long after treatments are […]